Fortress Biotech price target raised to $16 from $15 at Roth MKM
Roth MKM raised the firm’s price target on Fortress Biotech (FBIO) to $16 from $15 and keeps a Buy rating on the shares. The firm is adjusting ...
Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties
Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn ...
Fierce Pharma1d
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...
Three held with illegal weapons near Chandigarh jail, car seized
Considering the ongoing farmers’ rally and increased security measures in Chandigarh, the police took the three accused, ...